Celularity Inc. Files 8-K: Material Definitive Agreement
Ticker: CELUW · Form: 8-K · Filed: Aug 18, 2025 · CIK: 1752828
Sentiment: neutral
Topics: material-definitive-agreement, corporate-event
Related Tickers: CELU
TL;DR
Celularity Inc. signed a big deal on Aug 13th, filing an 8-K. Details to follow.
AI Summary
Celularity Inc. entered into a Material Definitive Agreement on August 13, 2025. The filing also includes other events and financial statements/exhibits. Celularity Inc. was formerly known as GX Acquisition Corp. and changed its name on September 12, 2018.
Why It Matters
This 8-K filing indicates a significant new agreement for Celularity Inc., which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material Definitive Agreements can introduce new risks or opportunities, and the specifics of this agreement are not detailed in the provided excerpt.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- August 13, 2025 (date) — Date of earliest event reported
- GX Acquisition Corp. (company) — Former company name
- September 12, 2018 (date) — Date of name change
FAQ
What is the nature of the Material Definitive Agreement entered into by Celularity Inc. on August 13, 2025?
The provided excerpt does not specify the details of the Material Definitive Agreement, only that one was entered into on August 13, 2025.
What other events are reported in this 8-K filing?
The filing indicates 'Other Events' are reported, but the specifics are not detailed in the provided text.
Does this filing include financial statements?
Yes, the filing explicitly lists 'Financial Statements and Exhibits' as an item information.
When was Celularity Inc. previously known by another name?
Celularity Inc. was formerly known as GX Acquisition Corp., with a name change occurring on September 12, 2018.
What is Celularity Inc.'s state of incorporation and fiscal year end?
Celularity Inc. is incorporated in Delaware and its fiscal year ends on December 31.
Filing Stats: 1,762 words · 7 min read · ~6 pages · Grade level 13.4 · Accepted 2025-08-18 16:30:34
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share CELU The Nasdaq
- $11.50 — A Common Stock at an exercise price of $11.50 per share CELUW The Nasdaq Stock Ma
- $33,812,230 — ned in the APA) for a purchase price of $33,812,230 (the "Purchase Price"). The Company use
- $27,000,000 — (i) the loan in the principal amount of $27,000,000 outstanding pursuant to that certain Se
- $6,812,230 — ii) the loan in the principal amount of $6,812,230 evidenced by that certain promissory no
Filing Documents
- form8-k.htm (8-K) — 58KB
- ex10-1.htm (EX-10.1) — 173KB
- ex10-2.htm (EX-10.2) — 128KB
- ex99-1.htm (EX-99.1) — 21KB
- 0001641172-25-024623.txt ( ) — 656KB
- celu-20250813.xsd (EX-101.SCH) — 4KB
- celu-20250813_def.xml (EX-101.DEF) — 26KB
- celu-20250813_lab.xml (EX-101.LAB) — 36KB
- celu-20250813_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELULARITY INC . Dated: August 18, 2025 By: /s/ Robert J. Hariri Name: Robert J. Hariri, M.D., Ph.D. Title: Chairman and CEO -4-